Conformis, Inc. Common Stock
CFMS
CFMS 종목은 2023년 9월 1일에 상장 폐지됐어요.
소개: Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
직원 수: 295
뉴스
CFMS에 대한 최신 뉴스 기사를 아직 받지 못했어요.